Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

Detalles Bibliográficos
Autores principales: Bruijstens, Arlette L, Blok, Katelijn M, Smolders, Joost, Wokke, Beatrijs HA, Neuteboom, Rinze F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720353/
https://www.ncbi.nlm.nih.gov/pubmed/32406801
http://dx.doi.org/10.1177/1352458520921367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720353/
https://www.ncbi.nlm.nih.gov/pubmed/32406801
http://dx.doi.org/10.1177/1352458520921367

Ejemplares similares